Lausanne

AC Immune Holds its Annual General Meeting of Shareholders

Retrieved on: 
Friday, June 25, 2021

LAUSANNE, Switzerland, June 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that AC Immune held its Annual General Meeting per Swiss law.

Key Points: 
  • LAUSANNE, Switzerland, June 25, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that AC Immune held its Annual General Meeting per Swiss law.
  • Shareholders cast their votes through the independent proxy appointed by the shareholders.
  • Douglas Williams, Chairman of the Board of Directors of AC Immune, commented: Despite impact from COVID-19, AC Immune has maintained its business on track.
  • I am thankful to our Shareholders for their trust in the Board to lead AC Immune in its next phase of development.

Best Prime Day Logitech Deals 2021: Best Early Logitech Webcam, Harmony, Mouse, Keyboard & More Deals Rounded Up by The Consumer Post

Retrieved on: 
Sunday, June 20, 2021

Save up to 51% on best-selling Logitech gaming headsets at Amazon - view best prices on Logitech wired & wireless stereo & surround sound gaming headsets for PC, Xbox & PlayStation consoles

Key Points: 
  • Save up to 51% on best-selling Logitech gaming headsets at Amazon - view best prices on Logitech wired & wireless stereo & surround sound gaming headsets for PC, Xbox & PlayStation consoles
    Want some more deals?
  • Check out Walmarts Deals for Days sale and Amazons Prime Day homepage to view thousands more savings across a broad range of products.
  • The Consumer Post earns commissions from purchases made using the links provided.
  • About The Consumer Post: The Consumer Post shares news for online shoppers.

Logitech Marks Milestone in Conflict-Free Minerals Commitment

Retrieved on: 
Thursday, June 10, 2021

Now, all Logitech products are verified as being made only with minerals and resulting metals that comply with conflict-free standards.

Key Points: 
  • Now, all Logitech products are verified as being made only with minerals and resulting metals that comply with conflict-free standards.
  • Additionally, 100% of in-scope smelter suppliers are now participating in a third-party responsible minerals sourcing audit program.
  • Logitech is dedicated to pursuing transparency throughout our supply chain, promoting responsible sourcing, and the avoidance of conflict minerals worldwide, said Prakash Arunkundrum, Head of Global Operations and Sustainability at Logitech.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Blue Microphones , Ultimate Ears and Jaybird .

AC Immune Provides Update on Alzheimer’s Disease Vaccine Candidates Targeting Pathological Amyloid-Beta

Retrieved on: 
Wednesday, June 2, 2021

In non-human primates, vaccination with the optimized ACI-24 vaccine generated a strong, conformation-specific antibody response against oligomeric and pyroGlu-Abeta .

Key Points: 
  • In non-human primates, vaccination with the optimized ACI-24 vaccine generated a strong, conformation-specific antibody response against oligomeric and pyroGlu-Abeta .
  • AC Immune will complete the Phase 2 study with the 24-month analysis on the basis of currently enrolled patients.
  • AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimers disease, Parkinsons disease, and NeuroOrphan indications driven by misfolded proteins.
  • SupraAntigen and Morphomer are registered trademarks of AC Immune SA in the following territories: AU, CH, EU, JP, and GB.

AC Immune to Highlight First-in-Class Alzheimer’s Disease Vaccine Programs at Upcoming Investor Conferences

Retrieved on: 
Thursday, May 20, 2021

b'LAUSANNE, Switzerland, May 20, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will participate in the UBS Global Healthcare Virtual Conference and the Jefferies Virtual Healthcare Conference, taking place May 24-26, 2021 and June 1-4, 2021, respectively.\nDuring the conferences, Prof. Andrea Pfeifer, CEO, AC Immune SA will discuss the Company\xe2\x80\x99s corporate strategy and precision medicine approach, while highlighting its clinical-stage Alzheimer\xe2\x80\x99s disease vaccine programs targeting phospho-Tau and Abeta.

Key Points: 
  • b'LAUSANNE, Switzerland, May 20, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that it will participate in the UBS Global Healthcare Virtual Conference and the Jefferies Virtual Healthcare Conference, taking place May 24-26, 2021 and June 1-4, 2021, respectively.\nDuring the conferences, Prof. Andrea Pfeifer, CEO, AC Immune SA will discuss the Company\xe2\x80\x99s corporate strategy and precision medicine approach, while highlighting its clinical-stage Alzheimer\xe2\x80\x99s disease vaccine programs targeting phospho-Tau and Abeta.
  • Details of the upcoming presentations are shown below.\nA webcast of the corporate presentation and fireside chat will be available on the Events Page of AC Immune\xe2\x80\x99s website.\nAC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer\xe2\x80\x99s disease, Parkinson\xe2\x80\x99s disease, and NeuroOrphan indications driven by misfolded proteins.
  • The Company\xe2\x80\x99s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials.
  • AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.\n'

Logitech Introduces a Collaborative Whiteboard Solution For Hybrid Offices and Classrooms

Retrieved on: 
Tuesday, May 18, 2021

b'Today, Logitech (SIX: LOGN) (NASDAQ:LOGI) is creating a more equitable meeting experience for remote participants with the launch of Logitech Scribe , an AI-powered whiteboard camera.

Key Points: 
  • b'Today, Logitech (SIX: LOGN) (NASDAQ:LOGI) is creating a more equitable meeting experience for remote participants with the launch of Logitech Scribe , an AI-powered whiteboard camera.
  • View the full release here: https://www.businesswire.com/news/home/20210518005397/en/\nLogitech Scribe AI-powered whiteboard camera for video meetings and hybrid learning (Photo: Business Wire)\nFrom meeting rooms to classrooms, Logitech Scribe comes at a crucial time when hybrid work and learning has become more pervasive.
  • Logitech Scribe makes brainstorming, teaching, and team meetings equally accessible and productive for all participants through its simple-to-use design.
  • In-room participants can begin sharing whiteboard content into video meetings by simply pressing the wireless button included with Scribe or tapping the meeting room touch controller, like Logitech Tap .

Solotech Reaffirms Its Position as the Leading Canadian Partner for Professional AV Services and Solutions with the Acquisition of CBCI Telecom

Retrieved on: 
Monday, May 17, 2021

b'MONTREAL, May 17, 2021 /CNW Telbec/ - As part of its growth strategy, Solotech is pleased to announce today the acquisition of CBCI Telecom Canada Inc. (CBCI).

Key Points: 
  • b'MONTREAL, May 17, 2021 /CNW Telbec/ - As part of its growth strategy, Solotech is pleased to announce today the acquisition of CBCI Telecom Canada Inc. (CBCI).
  • CBCI is a Canadian leader in providing the most comprehensive audiovisual and video conferencing solutions.
  • Cisco, Microsoft Teams and Logitech solutions are part of its service offering, including personalized cloud services and video conferencing interconnection.
  • This transaction aligns perfectly with our growth strategy and confirms our position as the number one Canadian leader in sales and integration of audiovisual systems.

AC Immune Announces Expansion of Phase 1b/2a phospho-Tau Alzheimer’s Vaccine Trial and Provides a Program Update

Retrieved on: 
Monday, May 17, 2021

The trial expansion, which is based on encouraging interim safety, tolerability and immunogenicity results to date, specifically includes vaccination of additional AD patients at the second highest dose to support continued development of ACI-35.030 into Phase 2b/3.

Key Points: 
  • The trial expansion, which is based on encouraging interim safety, tolerability and immunogenicity results to date, specifically includes vaccination of additional AD patients at the second highest dose to support continued development of ACI-35.030 into Phase 2b/3.
  • ACI-35.030 is the first AD vaccine candidate designed to generate antibodies that specifically target pathological pTau proteins in the brain.
  • Andrea Pfeifer, CEO of AC Immune SA, commented: \xe2\x80\x9cExpanding the second highest dose cohort will increase the amount of immunogenicity and safety data and potentially facilitate advancement into a Phase 2b/3 trial.
  • Antibodies generated by the platform are highly specific for the pathological conformations of misfolded proteins and have shown strong safety.

Logitech Files Annual Report on Form 10-K

Retrieved on: 
Wednesday, May 12, 2021

b"Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it filed its Annual Report on Form 10-K for Fiscal Year 2021 with the U.S. Securities and Exchange Commission (SEC).

Key Points: 
  • b"Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it filed its Annual Report on Form 10-K for Fiscal Year 2021 with the U.S. Securities and Exchange Commission (SEC).
  • Logitech expects to publish its annual report to shareholders, and its invitation and proxy statement for its 2021 annual general meeting, in July 2021.\nLogitech designs products that have an everyday place in people's lives, connecting them to the digital experiences they care about.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Blue Microphones , Ultimate Ears and Jaybird .
  • Find Logitech at www.logitech.com , the company blog or @Logitech .\nLogitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A and/or its affiliates in the U.S. and other countries.

Oculis Announces Positive Data from Two Proof-of-Concept Phase 2 Trials with OCS-02, a Novel Topical TNF alpha Antagonist, in Dry Eye Disease and Acute Anterior Uveitis, Presented at ARVO 2021

Retrieved on: 
Tuesday, May 11, 2021

The data were presented for the first time at ARVO 2021, the annual meeting of the Association for Research in Vision and Ophthalmology, which took place virtually from May 1-7, 2021.\nRiad Sherif, M.D.

Key Points: 
  • The data were presented for the first time at ARVO 2021, the annual meeting of the Association for Research in Vision and Ophthalmology, which took place virtually from May 1-7, 2021.\nRiad Sherif, M.D.
  • Chief Executive Officer of Oculis said: \xe2\x80\x9cWe are very excited to present these data for the first time at ARVO 2021.
  • The data from these two Phase 2 trials highlight the potential of OCS-02 in key indications that affect the anterior segment of the eye and have serious implications for the sight and well-being of patients.
  • Additional studies are needed to better understand the role of unique gene variants in DED and susceptibility to anti-TNF\xce\xb1 therapies.